International Mito Patients (IMP): Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Beno Marija (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
::::Elja van der Veer (The Netherlands) | ::::Elja van der Veer (The Netherlands) | ||
::::Main responsibility: general management, project harmful drugs for mito’s | ::::Main responsibility: general management, project harmful drugs for mito’s | ||
::::[mailto:[email protected] [email protected]] | ::::E-Mail: [mailto:[email protected] [email protected]] | ||
===Business address=== | ===Business address=== | ||
| Line 20: | Line 20: | ||
::::Burg. Uilkensstraat 21 | ::::Burg. Uilkensstraat 21 | ||
::::2861 AD Bergambacht - The Netherlands | ::::2861 AD Bergambacht - The Netherlands | ||
::::E-mail: [mailto:[email protected] [email protected]] | |||
Revision as of 11:10, 23 March 2017
- high-resolution terminology - matching measurements at high-resolution
International Mito Patients (IMP)
Description
The International Mito Patients is a network of national patient organizations involved in mitochondrial disease. Mitochondrial disease is a rare disease with a limited number of patients per country. The national patient organizations which are a member of IMP each are active and powerful in their own countries. By joining forces IMP can represent a large group of patients and as such be their voice on an international level.
Abbreviation: IMP
Reference: MitoPatients
MitoPedia topics:
MitoGlobal Organizations
Contact details
Chairman
- Elja van der Veer (The Netherlands)
- Main responsibility: general management, project harmful drugs for mito’s
- E-Mail: [email protected]
Business address
- International Mito Patients
- Burg. Uilkensstraat 21
- 2861 AD Bergambacht - The Netherlands
- E-mail: [email protected]
